Alpha Tau Medical Stock Price To Earnings To Growth
DRTS Stock | USD 3.09 0.01 0.32% |
Alpha Tau Medical fundamentals help investors to digest information that contributes to Alpha Tau's financial success or failures. It also enables traders to predict the movement of Alpha Stock. The fundamental analysis module provides a way to measure Alpha Tau's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpha Tau stock.
Alpha |
Alpha Tau Medical Company Price To Earnings To Growth Analysis
Alpha Tau's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Alpha Tau Medical has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Alpha Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpha Tau's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpha Tau could also be used in its relative valuation, which is a method of valuing Alpha Tau by comparing valuation metrics of similar companies.Alpha Tau is currently under evaluation in price to earnings to growth category among its peers.
Alpha Tau ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alpha Tau's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alpha Tau's managers, analysts, and investors.Environmental | Governance | Social |
Alpha Fundamentals
Return On Equity | -0.33 | ||||
Return On Asset | -0.22 | ||||
Current Valuation | 163.96 M | ||||
Shares Outstanding | 70.1 M | ||||
Shares Owned By Insiders | 25.56 % | ||||
Shares Owned By Institutions | 1.95 % | ||||
Number Of Shares Shorted | 67.79 K | ||||
Price To Book | 3.12 X | ||||
EBITDA | (28.03 M) | ||||
Net Income | (29.16 M) | ||||
Cash And Equivalents | 112.04 M | ||||
Cash Per Share | 1.63 X | ||||
Total Debt | 13.28 M | ||||
Current Ratio | 41.98 X | ||||
Book Value Per Share | 1.21 X | ||||
Cash Flow From Operations | (17.96 M) | ||||
Short Ratio | 3.01 X | ||||
Earnings Per Share | (0.43) X | ||||
Target Price | 8.75 | ||||
Number Of Employees | 121 | ||||
Beta | 0.77 | ||||
Market Capitalization | 216.62 M | ||||
Total Asset | 107.39 M | ||||
Retained Earnings | (115.76 M) | ||||
Working Capital | 78.65 M | ||||
Net Asset | 107.39 M |
About Alpha Tau Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alpha Tau Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpha Tau using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpha Tau Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.